Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 13/20 | 1.00 |
| ▸ | HTR1A | P08908 | 4/20 | 0.78 |
| ▸ | ADRA2A | P08913 | 4/20 | 0.78 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.78 |
| ▸ | DRD2 | P14416 | 4/20 | 0.78 |
| ▸ | ADRA2C | P18825 | 4/20 | 0.78 |
| ▸ | DRD1 | P21728 | 4/20 | 0.78 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.78 |
| ▸ | HTR2A | P28223 | 4/20 | 0.78 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.78 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.78 |
| ▸ | HRH1 | P35367 | 4/20 | 0.78 |
| ▸ | DRD3 | P35462 | 4/20 | 0.78 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.78 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.78 |
| ▸ | LMNA | P02545 | 3/20 | 0.78 |
| ▸ | TP53 | P04637 | 3/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.78 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.78 |
| ▸ | MAPT | P10636 | 3/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Perazine SCHEMBL29390464 | 1.00 | KDM1A (1.00) | KDM1AHTR1AADRA2ACHRM1DRD2 | |
| Perazine SCHEMBL6644457 | 0.98 | KDM1A (0.97) | KDM1AHTR1AADRA2ACHRM1DRD2 | |
| Perazine SCHEMBL2237726 | 0.98 | KDM1A (0.97) | KDM1AHTR1AADRA2ACHRM1DRD2 | |
| SCHEMBL6859184 | 0.97 | KDM1A (0.94) | KDM1AHTR1AADRA2ACHRM1DRD2 | |
| Perazine SCHEMBL10531680 | 0.92 | KDM1A (0.84) | KDM1AHTR1AADRA2ACHRM1DRD2 | |
| SCHEMBL10973127 | 0.91 | KDM1A (0.84) | KDM1AHTR1AADRA2ACHRM1DRD2 | |
| SCHEMBL2615404 | 0.89 | KDM1A (0.80) | KDM1AHTR1AADRA2ACHRM1DRD2 | |
| Perazine SCHEMBL7654455 | 0.88 | CYP3A4 (0.82) | KDM1AHTR1AADRA2ACHRM1DRD2 | |
| SCHEMBL7594811 | 0.88 | KDM1A (0.78) | KDM1AHTR1AADRA2ACHRM1DRD2 | |
| SCHEMBL2548635 | 0.88 | KDM1A (0.78) | KDM1AHTR1AADRA2ACHRM1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2873 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| EP-3507371-B1 | COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM | UNIV RUTGERS (US) | 2026-01-28 | — | — | EP | claimed |
| US-12527754-B2 | Methods and compositions for preventing and treating metabolic syndrome induced by antipsychotic treatment and related diseases and conditions | TUFTS MEDICAL CENTER, INC. (US) | 2026-01-20 | — | — | US | claimed |
| EP-4618973-A1 | METHODS OF SWITCHING NEUROPSYCHIATRIC MEDICATIONS USING ULOTARONT | Sumitomo Pharma America, Inc. (US) | 2025-09-24 | — | — | EP | claimed |
| US-20250179064-A1 | BENZOQUINOLONE INHIBITORS OF VMAT2 | AUSPEX PHARMACEUTICALS LLC | 2025-06-05 | — | — | US | claimed |
| WO-2025101418-A1 | TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS IN PATIENTS WITH PROMINENT ANHEDONIA USING IRDABISANT AS A MONOTHERAPY OR IN COMBINATION WITH AN ANTIPSYCHOTIC AGENT | ALTO NEUROSCIENCE, INC. (US) | 2025-05-15 | — | — | WO | claimed |
| US-20250144092-A1 | TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS IN PATIENTS WITH PROMINENT ANHEDONIA USING IRDABISANT AS A MONOTHERAPY OR IN COMBINATION WITH AN ANTIPSYCHOTIC AGENT | ALTO NEUROSCIENCE, INC. | 2025-05-08 | — | — | US | claimed |
| WO-2024107681-A1 | METHODS OF SWITCHING NEUROPSYCHIATRIC MEDICATIONS USING ULOTARONT | SUMITOMO PHARMA AMERICA, INC. (US) | 2024-05-23 | — | — | WO | claimed |
| US-20240000810-A1 | USE OF CANNABINOIDS IN THE TREATMENT OF TOURETTE SYNDROME AND TIC DISORDERS | Orcosa Inc. (US) | 2024-01-04 | — | — | US | claimed |
| EP-3192499-B1 | CELLULOSE FIBRE BASED SUPPORT MATRICES FOR LAYERED PRODUCTS FOR ORAL AND PERORAL APPLICATION AND THEIR PREPARATION | GLATT GMBH (DE) | 2023-11-29 | — | — | EP | claimed |
| US-5785976-A | Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof | PHARMACIA & UPJOHN AB (SE) | 1998-07-28 | — | — | US | claimed |
| EP-0738257-A1 | NEW METHOD FOR N-CYCLOPROPYLATION OF AROMATIC AMINES, AS WELL AS COMPOUNDS AND COMPOSITIONS OBTAINED | SOMFAI, Eva, Dr. (HU) | 1996-10-23 | — | — | EP | claimed |
| EP-0707637-A1 | ENHANCEMENT OF LACCASE REACTIONS | NOVO NORDISK A/S (DK) | 1996-04-24 | — | — | EP | claimed |
| EP-0687172-A1 | SOLID LIPID PARTICLES, PARTICLES OF BIOACTIVE AGENTS AND METHODS FOR THE MANUFACTURE AND USE THEREOF | Pharmacia & Upjohn Aktiebolag (SE) | 1995-12-20 | — | — | EP | claimed |
| EP-0679183-A1 | ENHANCEMENT OF ENZYME REACTIONS | NOVO NORDISK A/S (DK) | 1995-11-02 | — | — | EP | claimed |
| CN-1110605-A | Method of treating fungal infections | LILLY CO ELI (US) | 1995-10-25 | — | — | CN | claimed |
| WO-1995002573-A2 | NEW METHOD FOR N-CYCLOPROPYLATION OF AROMATIC AMINES, AS WELL AS COMPOUNDS AND COMPOSITIONS OBTAINED | SOMFAI EVA (HU) | 1995-01-26 | — | — | WO | claimed |
| WO-1995001426-A1 | ENHANCEMENT OF LACCASE REACTIONS | NOVO NORDISK A/S (DK) | 1995-01-12 | — | — | WO | claimed |
| WO-1994020072-A1 | SOLID LIPID PARTICLES, PARTICLES OF BIOACTIVE AGENTS AND METHODS FOR THE MANUFACTURE AND USE THEREOF | PHARMACIA AB (SE) | 1994-09-15 | — | — | WO | claimed |
| WO-1994012621-A1 | ENHANCEMENT OF ENZYME REACTIONS | NOVO NORDISK (DK) | 1994-06-09 | — | — | WO | claimed |